AWM
GILD icon

Accredited Wealth Management’s Gilead Sciences GILD Stock Holding History

Accredited Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$746K Sell
375
-6,344
-94% -$721K 0.56% 36
2025
Q2 		$745K Hold
6,719
– – 0.6% 36
2025
Q1 		$753K Hold
6,719
– – 0.64% 29
2024
Q4 		$621K Buy
+6,719
New +$605K 0.54% 37

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Accredited Wealth Management's GILD Position: Q3 2025 in Review

Accredited Wealth Management reduced its Gilead Sciences (GILD) stake by 94% in Q3 2025, selling an estimated $721K and leaving 375 shares worth $746K. The position accounts for 0.56% of the portfolio, ranked #36.

Accredited Wealth Management first reported a position in GILD in Q4 2024 and has held it in 4 quarters since. The position peaked at $753K in Q1 2025. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Accredited Wealth Management held 375 shares of Gilead Sciences worth $746K as of Q3 2025.
  • Accredited Wealth Management sold 6,344 Gilead Sciences shares in Q3 2025, an estimated $721K.
  • Gilead Sciences made up 0.56% of Accredited Wealth Management's portfolio in Q3 2025, its #36 holding.
  • Accredited Wealth Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 4 quarters since.
  • Accredited Wealth Management's Gilead Sciences position peaked at $753K in Q1 2025.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Accredited Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.